Recombinant endothelial nitric oxide synthase-transduced human saphenous veins: Gene therapy to augment nitric oxide production in bypass conduits

Circulation

Volumn 96, Issue 9 SUPPL., 1997, Pages

  Cable, David G ^a   O'Brien, Timothy ^a   Schaff, Hartzell V ^a   Pompili, Vincent J ^b  

^a MAYO CLINIC   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenoviral vector; Gene therapy; Nitric oxide synthase; Organ chamber; Saphenous vein

Indexed keywords

BETA GALACTOSIDASE; CALCIUM IONOPHORE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; NORADRENALIN; RECOMBINANT ENZYME;

ADENOVIRUS; ADVENTITIA; ANIMAL TISSUE; ARTICLE; BIOASSAY; CLONING VECTOR; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOG; GENE THERAPY; GENE TRANSFER; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT GENE; SAPHENOUS VEIN GRAFT; VASCULAR ENDOTHELIUM; VEIN THROMBOSIS;

ADENOVIRIDAE; ANIMALS; CATTLE; DOGS; ENDOTHELIUM, VASCULAR; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT PROTEINS; SAPHENOUS VEIN;

EID: 0343307015     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Cameron A, Kemp HG Jr, Green GE. Bypass surgery with the internal mammary artery graft: 15-year follow-up. Circulation. 1986; 74(suppl 1):I-1130-I-1136.
2. Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internalmammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1-6.
3. Izzat MB, West RR, Bryan AJ, Angelini GD. Coronary artery bypass surgery: current practice in the United Kingdom. Br Heart J. 1994;71:382-385.
4. Grondin CM, Lespérance J, Bourassa MG, Pasternac A, Campeau L, Grondin P. Serial angiographic evaluation in 60 consecutive patients with aortocoronary artery vein grafts 2 weeks, 1 year, and 3 years after operation. J Thorac Cardiovasc Surg. 1974;67:1-6.
5. FitzGibbon GM, Leach AJ, Keon WJ, Burton JR, Kafka HP. Coronary bypass graft fate: angiographic study of 1,179 vein grafts early, one year, and five years after operation. J Thorac Cardiovasc Surg. 1986;91:773-778.
6. Grondin CM, Campeau L, Lesperance J, et al. Atherosclerotic changes in coronary vein grafts six years after operation: angiographic aspect in 110 patients. J Thorac Cardiovasc Surg. 1979;77: 24-31.
7. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-dcrived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84: 9265-9269.
8. Radomski MW, Palmer RM, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol. 1987;92:181-187.
9. Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol. 1987;92:639-646.
10. Schafer AI, Alexander RW, Handin RI. Inhibition of platelet function by organic nitrate vasodilators. Blood. 1980;55:649-654.
11. Nabel EG, Nabel GJ. Complex models for the study of gene function in cardiovascular biology. Annu Rev Physiol. 1994;56: 741-761.
12. Schneider MD, French BA. The advent of adenovirus: gene therapy for cardiovascular disease. Circulation. 1993;88:1937-1942.
13. Chen SJ, Wilson JM, Muller DW. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation. 1994;89:1922-1928.
14. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977;36:59-74.
15. Jones N, Shenk T. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell. 1979;17:683-689.
16. Spector DJ, Samaniego LA. Construction and isolation of recombinant adenovirus with gene replacements. Methods Mol Genet. 1995;7:31-44.
17. Volkert FC, Young CS. The genetic analysis of recombination using adenovirus overlapping terminal DNA fragments. Virology. 1983; 125:175-193.
18. Feigner PL. Particulate systems and polymers for in vitro and in vivo delivery of polynucleotides. Adv Drug Delivery Rev. 1990;5: 163-187.
19. Sanes JR, Rubenstein JL, Nicolas JF. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J. 1986;5:3133-3142.
20. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem. 1993;214:11-16.
21. Pearson PJ, Schaff HV, Vanhoutte PM. Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circ Res. 1990;67: 385-393.
22. Iqbal A, Vanhoutte PM. Flunarizine inhibits endothelium-dependent hypoxic facilitation in canine coronary arteries through an action on vascular smooth muscle. Br J Pharmacol. 1988;95: 789-794.
23. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 1986;250: H1145-H1149.
24. Pearson PJ, Evora PR, Schaff HV. Bioassay of EDRF from internal mammary arteries: implications for early and late bypass graft patency. Ann Thorac Surg. 1992;54:1078-1084.
25. Lüscher TF, Diederich D, Siebenmann R, et al. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med. 1988;319:462-467.
26. Knowles RG, Moncada S. Nitric oxide as a signal in blood vessels. Trends Biochem Sci. 1992;17:399-402.
27. Thorin-Trescases N, Hamilton CA, Reid JL, et al. Inducible L-arginine/nitric oxide pathway in human internal mammary artery and saphenous vein. Am J Physiol. 1995;268:H1122-H1132.
28. Yang ZH, von Segesser L, Bauer E, Stulz P, Turina M, Lüscher TF. Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein. Circ Res. 1991;68:52-60.
29. Chua YL, Pearson PJ, Evora PR, Schaff HV. Detection of intraluminal release of endothelium-derived relaxing factor from human saphenous veins. Circulation. 1993;88:II128-II132.
30. Dries D, Mohammed SF, Woodward SC, Nelson RM. The influence of harvesting technique on endothelial preservation in saphenous veins. J Surg Res. 1992;52:219-225.
31. Moore KP, Darley-Usmar V, Morrow J, Roberts LJ II. Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite. Circ Res. 1995;77:335-341.
32. Szabo C, Salzman AL, Ischiropoulos H. Endotoxin triggers the expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in the rat aorta in vivo. FEBS Lett. 1995;363:235-238.
33. Moro MA, Darley-Usmar VM, Goodwin DA, et al. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci U S A. 1994;91:6702-6706.
34. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest. 1993;92:883-893.
35. Engelhardt JF, Simon RH, Yang Y, et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum Gene Ther. 1993;4:759-769.
36. Lemarchand P, Jaffe HA, Danel C, et al. Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. Proc Natl Acad Sci U S A. 1992;89: 6482-6486.
37. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A. 1994;91:4407-4411.
38. Engelhardt JF, Litzky L, Wilson JM. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2A. Hum Gene Ther. 1994;5:1217-1229.
39. Kozarsky KF, McKinley DR, Austin LL, Raper SE, Stratford-Perricaudet LD, Wilson JM. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem. 1994; 269:13695-13702.
40. Ueno H, Li JJ, Tomita H, et al. Quantitative analysis of repeat adenovirus-mediated gene transfer into injured canine femoral arteries. Arterioscler Thromb Vase Biol. 1995;15:2246-2253.
41. Newman KD, Dunn PF, Owens JW, et al. Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. J Clin Invest. 1995;96:2955-2965.